Objective: The status of the axilla is the single most important prognostic indicator of overall survival in patients with breast cancer. Sentinel-node biopsy has false-negative rates of 5 -10%. The aim of this study was to assess the importance of tumor and breast volume ratio as a predictive factor for axillary lymph node metastases in patients with T1c ductal invasive breast cancer. Methods: This study included 136 consecutive patients with T1c ductal invasive breast cancer. Three tumor diameters were measured. Tumor volume was calculated by the formula for ellipse. Breast volume was measured preoperatively. Tumor and breast volume ratio was calculated and shown per thousand. Results: Tumor and breast volume ratio is a new independent predictive factor for axillary lymph node metastase in T1c ductal invasive breast cancer. Conclusions: This predictive factor could help to define a subgroup of patients who will be at a higher risk for axillary lymph node metastase and would benefit from additional close follow up or axillary lymph node dissection.
INTRODUCTION
Breast-conserving treatment is now regarded as a standard local treatment for early breast cancer (1, 2) . The status of the axilla is the single most important prognostic indicator of overall survival in patients with breast cancer (1 -4) . Breast cancer staging is based on tumor size and on the presence of lymph node metastases according to the American Joint Committee on Cancer (AJCC)/International Union against Cancer (UICC) classification (5) . As screening mammography and breast cancer awareness increased, the percentage of patients with positive lymph nodes decreased to 30%. The 70% node-negative patients do not benefit from axillary lymph node dissection (ALND) but may be suffered from its attendant complications (1) . For years, levels I and II ALND has remained the standard approach to breast cancer lymphatic staging (1, 6) . The value of ALND is still high, but the development of sentinel-node biopsy (SNB) has significantly changed the indication of the procedure (7) . SNB is a widely accepted procedure for nodal staging with accuracy in predicting the involvement of the axillary nodes of 93 -100% (8 -12) . SNB provides prognostic information with less surgical morbidity than ALND (13 -16) . In women with clinically node-negative early-stage breast cancer, SNB is now adopted as the preferred method for staging of axillary lymph nodes (1,3,11 -13,17 -20). For those with positive sentinel lymph node (SLN), including micrometastases, the standard surgical treatment is ALND (1) .
Multiple published trials produced false-negative rates for SNB of 5 -10% (13, 21, 22) . Information from the prospective randomized phase III trial NSABP-B32 shows a falsenegative rate of 9.8% (21) . It is very important to identify independent predictive factors for axillary lymph node metastases (ALNMs) to reduce the false-negative rate. Independent predictors of node positivity are tumor size, the presence of lymphovascular invasion (LVI), histological type and grade (23 -25) . The single most powerful predictor of lymph node metastases is LVI (23, 26) , associated with a 5.3-fold greater risk for ALNMs.
Tumor volume, breast volume and tumor and breast volume ratio have not been previously investigated as a predictive factors for ALNM.
The aim of this study was to assess the importance of tumor and breast volume ratio as a predictive factor for ALNM in T1c ductal invasive breast cancer. The proposed predictive factor could help a define subgroup of patients with T1c ductal invasive cancer who will be at a higher risk for ALNM.
PATIENTS AND METHODS
One hundred and thirty-six consecutive patients with T1c node-negative ductal invasive breast cancer have been treated at our Department, from 1 January 2007 to 31 December 2009. We included only ductal invasive breast cancer between 1 and 2 cm, because we tried to get more homogenous group and at the same time we respected the tumor-node-metastasis (TNM) system of the AJCC/UICC classification. All patients had clinically negative lymph nodes and underwent level I/II ALND as part of their treatment for breast cancer. In all patients ultrasound (US) and/or magnetic resonance imaging (MRI) scan are used for preoperative evaluation of tumor and axillary lymph node status. If necessary US-guided fine needle aspiration cytology (FNAC) of suspected lymph nodes was made. Patients were treated with breast-conserving surgery, mastectomy or skin and nipple-sparing mastectomy (SNSM) and immediate reconstruction with latissimus dorsi regional flap or prosthesis. All tumors and lymph nodes were submitted for histological examination after surgery. Patients who had multicentric cancer, preoperatively confirmed ALNM, or previously undergone excisional biopsy, radiotherapy, chemotherapy or hormonal therapy, were excluded from study. Breast volume was measured preoperatively according to a device based on Archimedes' principle described in article of Tezel and Numanogly (27) . We used a container large enough to embrace the breast, without putting any pressure on the breast. A 2 -3 cm hole was made in the center of the bottom of the container. The open edge of the bag was pulled through this hole. The device was placed on the breast of the patient lying in supine position. The bag was filled with warm water. The volume of the used water was measured. The difference between container volume and volume of used water represents breast volume in milliliters (cm 3 ). The measurement is very easy and takes 1 -2 min. There were no complaints by patients. Tumors were classified using the TNM system of the UICC (28) . The gross specimens of tumors were measured employing a millimeter ruler and the size was presented in 1 mm increments. T stage was determined by measuring the largest dimension of the invasive carcinoma ( pT). We measured three tumor diameters. The measurement was confirmed microscopically on histological slides. Histological slides were obtained from formalin-fixed tumor tissue which was sectioned in 2 mm wide tissue blocks and each block embedded in paraffin. Tumor volume was calculated by the formula for the ellipse V ¼ p/6*(a*b*c), in which 'a', 'b' and 'c' represents the tumor diameters (29) . Histological characteristics of the primary tumor, growth pattern, grade of differentiation and occurrence of peritumoral LVI were evaluated on routine hematoxyllin and eosin slides. The histological classification was based on the World Health Organization classification of tumors (30) . Tumors were graded according to the system of Elston and Ellis, where I indicates well differentiated, II moderately differentiated and III poorly differentiated (31) . The expression of estrogen (ER) and progesteron (PR) receptors were evaluated immunohistochemically. Human epidermal growth factor receptor 2 (HER-2)/neu over expression was also investigated imunohistochemically by Herceptest and when necessary by fluorescence in situ hybridization. After pathohistological evaluation, the exact tumor size and histology were determined and all patients who did not fit the study design were excluded. Tumor and breast volume ratio were calculated and shown per thousands for easier manipulation with results. It was a single center prospective observational study. The study was approved by the Ethics Committee of the University Hospital Dubrava. Written informed consent was obtained from all patients in this study. Statistical analyses: Receiver operating characteristic (ROC) curve was generated for quantitative variables (age, tumor volume and tumor and breast volume ratio). Qualitative variables were tested on x 2 test to assess the relationship to nodal involvement. In a multivariate logistic regression model, we included four predictive factors: LVI, tumor and breast volume ratio, tumor volume and histological grade.
STATISTICA 8.0 (StatSoft Inc., Tulsa, OK, USA) statistical software was used.
RESULTS
ALNMs were presented in 42 of 136 patients (30.9%). The data about the patients are summarized in Table 1 .
The age was between 26 and 81 years, with median of 57.5 for node negative and 54.62 for node-positive group. In 19 patients (45.2%) by preoperative US or MRI metastatic lymph nodes had been detected or highly suspected (18 patients detected by US-3 had positive FNAC; one patient detected by MRI was negative on US). Other 23 patients (54.8%) had negative results for axillary metastases by US (12 patients had negative results; 11 patients had nonsuspected reactive lymph nodes and 3 patients among them had negative FNAC). Tumor volumes in node-negative group were between 0.13 and 3.14 cm 3 , median 0.68; in node-positive group between 0.18 and 2.91 cm 3 , median 0.98. Median for tumor and breast volume ratio in nodepositive group was higher (median 2.25; min 0.34, max 10.56) than in node-negative group (median 1.29; min 0.12; max 9.98). ROC curve showed that tumor volume (P ¼ 0.001) and tumor and breast volume ratio (P , 0.001) achieved significance as predictive factors for ALNM (Fig. 1) .
The area under the curve (AUC) for the tumor volume was 0.673 [95% confidence interval (CI) was 0.576 -0.770] P ¼ 0.001 and for tumor and breast volumes ratio the AUC was 0.740 (95% CI was 0.653 -0.826) P , 0.001. The AUC for tumor and breast volumes ratio was greater than the AUC for tumor volume and suggest better prediction for ALNM. Age did not achieve statistical significance.
Tumor grade and LVI on univariate analysis showed significance in prediction of ALNM. as the predictive factors for ALNM while tumor volume and histological grade did not achieve statistical significance (Table 2 ). These four variables together (tumor and breast volume ratio, tumor volume, tumor grade and LVI) in logistic regression model had 73.5% of chance to predict the true status of axillary lymph nodes (cut-off value is 0.5).
DISCUSSION
The prospective randomized phase III trial NSABP-B32 showed a 9.8% false-negative rate of SNB (21) warning us that SNB is a method that still needs to be evaluated in T1c and T2 breast cancer patients. The SNB failed to predict the true nodal status in 5 of 58 node-positive patients (falsenegative rate of 8.6%) with extensive nodal involvement in a study conducted by De Kanter et al. In such patients, both the radioactive tracer and the blue dye were accumulated in the non-sentinel nodes (NSNs), causing a false-negative result (32) . Barth et al. (23) showed that T1c tumors with LVI, high tumor grade (II and III) and palpability preoperatively had an incidence of ALNM of 49% while small tumors without these three additional factors had an incidence of ALNM of 3% in series of 918 patients. Tumor larger than 2 cm with LVI are at the highest risk for axillary lymph node involvement and immediate ALND could be recommended without a preliminary SNB (26) .
Is it acceptable to avoid axillary dissection with a negative sentinel node, especially when the false-negative rate is 9.8% (21) .
It is very important to reduce false-negative rate of SNB in these groups below 5% or less. The main issue is how to determine false-negative patients on SNB and perform ALND to reduce the false-negative results. The combination of SNB with independent predictive clinico-pathological factors for ALNM in breast cancer could be the solution for solving this problem. Some authors described clinicopathological score for counseling and selecting patients for SNB or ALND. Olivotto et al. (33) proposed three-variable model employing tumor and lymph node palpability, tumor size and LVI to estimate the risk of ALNM. Carmichael et al. use five predictors (size of primary tumor, age, grade, quadrant of the breast and LVI) to make scoring system. A score of 10 was used to differentiate patients into high-risk and low-risk groups. The number of patients with positive nodes increased with increasing score (24, 25) .
In their study they also included tumors larger than 2 cm. Viale et al. (26) showed that tumors larger than 2 cm could significantly influence the results. In our study, we did not include tumors larger than 2 cm to avoid this influence, so we had a homogenous group of patients according to tumor size and histological type.
Our study revealed a new independent predictive factor (tumor and breast volume ratio) for ALNM in T1c ductal invasive breast cancer and confirmed LVI as a single most important predictive factor in multivariate analysis (23, 24, 26) . According to our knowledge, this is the first study that describes tumor volume and tumor and breast volume ratio as a predictive factor for ALNM. Histological grade and tumor volume in T1c ductal invasive breast cancer had statistical significance only in univariate analysis. Other predictive factors in our study did not show statistical significance. Our study introduced this new predictive factor for ALNM. Tumor and breast volume ratio as a new predictive factor together with other clinico-pathological predictive factors could help to detect patients with T1c ductal invasive breast cancer at a higher risk of ALNM. Together with LVI histological grade had 73.5% of chance to predict the true status of axillary lymph nodes.
SNB is a widely accepted method for nodal staging, with false-negative rates of 5 -10%. According to recent literature, it is wise to routinely conduct SNB in T1c ductal invasive breast cancer. If SLN is positive level I/II axillary dissection should be performed (1, 3) . To prevent false-negative results in patients with negative SLN who had high risk of metastases according to predictive clinico-pathological factors, additional close follow-up or ALND could be performed. Our new predictive factor could be helpful in detecting the group of patients at a higher risk for ALNM.
Additional prospective clinical trials are needed to evaluate this hypothesis.
